Autor: "Yang D" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Multifunctional Novel Nanoplatform for Effective Synergistic Chemo-Photodynamic Therapy of Breast Cancer by Enhancing DNA Damage and Disruptions of Its Reparation.
Autorzy:: Huang Z; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy, Chongqing University of Arts and Sciences, Chongqing 402160, China.; Key Laboratory of Bio-Theological Science and Technology of Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400045, China.
Xian T; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Meng X; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Hu H; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Gao L; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Huang J; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Yang D; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Ou K; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Wang B; Key Laboratory of Bio-Theological Science and Technology of Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400045, China.
Zhang Y; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy, Chongqing University of Arts and Sciences, Chongqing 402160, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2023 Oct 07; Vol. 28 (19). Date of Electronic Publication: 2023 Oct 07.
Typ publikacji:: Journal Article
MeSH Terms:: Photochemotherapy*
Antineoplastic Agents*
Nanoparticles*
Triple Negative Breast Neoplasms*
Humans ; Photosensitizing Agents/pharmacology ; Reactive Oxygen Species/metabolism ; Poly(ADP-ribose) Polymerases/metabolism ; DNA Damage ; Cell Line, Tumor ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Antiproliferative Evaluation of Novel 4-Imidazolidinone Derivatives as Anticancer Agent Which Triggers ROS-Dependent Apoptosis in Colorectal Cancer Cell.
Autorzy:: Huang J; College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, IATTI, Chongqing University of Arts and Sciences, Chongqing 402160, China.; College of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China.; Chongqing Academy of Chinese Materia Medica, Chongqing 400065, China.
Wang J; College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, IATTI, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Song G; College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, IATTI, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Hu C; College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, IATTI, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Xu Z; College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, IATTI, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Chen Z; College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, IATTI, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Xu C; College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, IATTI, Chongqing University of Arts and Sciences, Chongqing 402160, China.; Department of Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610041, China.
Yang D; College of Pharmacy, National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, IATTI, Chongqing University of Arts and Sciences, Chongqing 402160, China.; College of Pharmaceutical Sciences, Southwest University, Chongqing 400716, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2022 Dec 13; Vol. 27 (24). Date of Electronic Publication: 2022 Dec 13.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents*/pharmacology
Antineoplastic Agents*/therapeutic use
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/metabolism
Humans ; Reactive Oxygen Species/metabolism ; Cell Line, Tumor ; Cell Proliferation ; Apoptosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Proteasomal deubiquitylase activity enhances cell surface recycling of the epidermal growth factor receptor in non-small cell lung cancer.
Autorzy:: Wang S; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Wang T; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Yang Q; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Cheng S; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Liu F; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Yang G; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Wang F; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Wang R; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Yang D; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Zhou M; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Duan C; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Zhang Y; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Liu H; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China.
Dai Z; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China. .; The Second Department of Thoracic Medical Oncology, The Second Hospital of Dalian Medical University, 467 Zhongshan Road, Shahekou District, 116027, Dalian, Liaoning Province, P. R. China. .
Tian K; Department of Bone and Joint, First Affiliated Hospital, Dalian Medical University, Dalian, China. .; Biomaterials Innovation Research Center, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. .; Department of Orthopedic Sports Medicine, First Affiliated Hospital, Dalian Medical University, 222 Zhongshan Road, 116044, Dalian, Liaoning Province, P. R. China. .
Liu S; Second Affiliated Hospital, Institute of Cancer Stem Cell, Dalian Medical University, Dalian, China. .; Institute of Cancer Stem Cell, Dalian Medical University, 9 West Sec. Lvshun South Road, 116044, Dalian, Liaoning Province, P. R. China. .; Pokaż więcej
Źródło:: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2022 Oct; Vol. 45 (5), pp. 951-965. Date of Electronic Publication: 2022 Sep 21.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents*/pharmacology
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Animals ; Humans ; Mice ; Apoptosis ; Cell Line, Tumor ; Epidermal Growth Factor/pharmacology ; ErbB Receptors/metabolism ; Mice, Nude ; Proteasome Inhibitors/pharmacology ; Ubiquitin Thiolesterase/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Design, Synthesis, and Biological Evaluation of N14-Amino Acid-Substituted Tetrandrine Derivatives as Potential Antitumor Agents against Human Colorectal Cancer.
Autorzy:: Wang YC; State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China.; Center for Tissue Engineering and Stem Cell Research, Key Laboratory of Regenerative Medicine of Guizhou Province, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550004, China.; School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China.
Zhang RH; State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China.; Center for Tissue Engineering and Stem Cell Research, Key Laboratory of Regenerative Medicine of Guizhou Province, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550004, China.
Hu SC; State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China.
Zhang H; School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China.
Yang D; School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China.
Zhang WL; School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China.
Zhao YL; School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China.
Cui DB; Center for Tissue Engineering and Stem Cell Research, Key Laboratory of Regenerative Medicine of Guizhou Province, School of Basic Medical Sciences, Guizhou Medical University, Guiyang 550004, China.
Li YJ; State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China.; School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China.
Pan WD; State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China.
Liao SG; School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China.
Zhou M; State Key Laboratory of Functions and Applications of Medicinal Plants, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Education), Guizhou Medical University, Guiyang 550004, China.; School of Pharmacy, Guizhou Medical University, Guian New Districtc, Guiyang 550025, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2022 Jun 23; Vol. 27 (13). Date of Electronic Publication: 2022 Jun 23.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents*/chemistry
Colorectal Neoplasms*/drug therapy
Amino Acids/pharmacology ; Apoptosis ; Benzylisoquinolines ; Cell Line, Tumor ; Cell Proliferation ; Drug Screening Assays, Antitumor ; Endothelial Cells ; Humans ; Molecular Structure ; Structure-Activity Relationship

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Effects of food on the pharmacokinetics of ensartinib in healthy Chinese subjects.
Autorzy:: Shao R; Center of Clinical Pharmacology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Chen W; Center of Clinical Pharmacology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Ruan Z; Center of Clinical Pharmacology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Yang D; Center of Clinical Pharmacology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Chen W; Betta Pharmaceuticals, Hangzhou, China.
Li H; Betta Pharmaceuticals, Hangzhou, China.
Lou H; Center of Clinical Pharmacology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Chen J; Center of Clinical Pharmacology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Jiang B; Center of Clinical Pharmacology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.; Pokaż więcej
Źródło:: Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2022 Mar; Vol. 49 (3), pp. 360-369. Date of Electronic Publication: 2021 Dec 27.
Typ publikacji:: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Asian People*
Antineoplastic Agents/*pharmacokinetics
Food-Drug Interactions/*genetics
Piperazines/*pharmacokinetics
Pyridazines/*pharmacokinetics
Adult ; Antineoplastic Agents/administration & dosage ; Area Under Curve ; China ; Cross-Over Studies ; Dietary Fats ; Energy Intake ; Female ; Half-Life ; Humans ; Male ; Piperazines/administration & dosage ; Pyridazines/administration & dosage ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Design, synthesis, and biological evaluation of novel triazoloquinazolinone derivatives as SHP2 protein inhibitors.
Autorzy:: Luo R; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.; Guizhou Engineering Laboratory for Synthetic Drugs, Guiyang, China.
Wang Z; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China.
Luo D; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.; Guizhou Engineering Laboratory for Synthetic Drugs, Guiyang, China.
Qin Y; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.; Guizhou Engineering Laboratory for Synthetic Drugs, Guiyang, China.
Zhao C; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.; Guizhou Engineering Laboratory for Synthetic Drugs, Guiyang, China.
Yang D; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.; Guizhou Engineering Laboratory for Synthetic Drugs, Guiyang, China.
Lu T; School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, China.
Zhou Z; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.; Guizhou Engineering Laboratory for Synthetic Drugs, Guiyang, China.; Department of Dermatology, Affiliated Hospital of Guizhou Medical University, Guiyang, China.
Huang Z; School of Pharmaceutical Sciences, Guizhou University, Guiyang, China.; Guizhou Engineering Laboratory for Synthetic Drugs, Guiyang, China.; Pokaż więcej
Źródło:: Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2021 Dec; Vol. 36 (1), pp. 2170-2182.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Design*
Antineoplastic Agents/*pharmacology
Enzyme Inhibitors/*pharmacology
Protein Tyrosine Phosphatase, Non-Receptor Type 11/*antagonists & inhibitors
Quinazolinones/*pharmacology
Triazoles/*pharmacology
Animals ; Antineoplastic Agents/chemical synthesis ; Antineoplastic Agents/chemistry ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; Enzyme Inhibitors/chemical synthesis ; Enzyme Inhibitors/chemistry ; Humans ; Microsomes, Liver/chemistry ; Microsomes, Liver/metabolism ; Molecular Docking Simulation ; Molecular Structure ; Protein Tyrosine Phosphatase, Non-Receptor Type 11/metabolism ; Quinazolinones/chemical synthesis ; Quinazolinones/chemistry ; Rats ; Structure-Activity Relationship ; Triazoles/chemical synthesis ; Triazoles/chemistry

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Novel Marine Secondary Metabolites Worthy of Development as Anticancer Agents: A Review.
Autorzy:: Mbaoji FN; Guangxi Key Laboratory of Marine Natural Products and Combinatorial Biosynthesis Chemistry, Guangxi Beibu Gulf Marine Research Center, Guangxi Academy of Sciences, Nanning 530007, China.; College of Life Science and Technology of Guangxi University, Nanning 530004, China.; Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria.
Nweze JA; Guangxi Key Laboratory of Marine Natural Products and Combinatorial Biosynthesis Chemistry, Guangxi Beibu Gulf Marine Research Center, Guangxi Academy of Sciences, Nanning 530007, China.; Department of Science Laboratory Technology, Faculty of Physical Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria.; Department of Ecosystem Biology, Faculty of Science, University of South Bohemia in Ceske Budejovice, 37005 Ceske Budejovice, Czech Republic.; Soil and Water Research Infrastructure, Biology Centre, Czech Academy of Sciences, 37005 Ceske Budejovice, Czech Republic.
Yang L; Guangxi Biomass Industrialization Engineering Institute, National Engineering Research Center of Non-Food Biorefinery, State Key Laboratory of Non-Food Biomass, Guangxi Academy of Sciences, Nanning 530007, China.
Huang Y; Guangxi Key Laboratory of Marine Natural Products and Combinatorial Biosynthesis Chemistry, Guangxi Beibu Gulf Marine Research Center, Guangxi Academy of Sciences, Nanning 530007, China.
Huang S; Guangxi Key Laboratory of Marine Natural Products and Combinatorial Biosynthesis Chemistry, Guangxi Beibu Gulf Marine Research Center, Guangxi Academy of Sciences, Nanning 530007, China.
Onwuka AM; Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria.
Peter IE; Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria.
Mbaoji CC; Department of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria.
Jiang M; Guangxi Key Laboratory for Polysaccharide Materials and Modifications, School of Marine Sciences and Biotechnology, Guangxi University for Nationalities, Nanning 530008, China.
Zhang Y; College of Life Science and Technology of Guangxi University, Nanning 530004, China.
Pan L; Guangxi Biomass Industrialization Engineering Institute, National Engineering Research Center of Non-Food Biorefinery, State Key Laboratory of Non-Food Biomass, Guangxi Academy of Sciences, Nanning 530007, China.
Yang D; Guangxi Key Laboratory of Marine Natural Products and Combinatorial Biosynthesis Chemistry, Guangxi Beibu Gulf Marine Research Center, Guangxi Academy of Sciences, Nanning 530007, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2021 Sep 23; Vol. 26 (19). Date of Electronic Publication: 2021 Sep 23.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Antineoplastic Agents/*therapeutic use
Aquatic Organisms/*chemistry
Biological Products/*therapeutic use
Neoplasms/*drug therapy
Animals ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/pharmacology ; Biological Products/chemistry ; Biological Products/pharmacology ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Humans ; Secondary Metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Novel DNA Bis-Intercalator XR5944 as a Potent Anticancer Drug-Design and Mechanism of Action.
Autorzy:: Buric AJ; College of Pharmacy, Medicinal Chemistry and Molecular Pharmacology, 575 W Stadium Ave, Purdue University, West Lafayette, IN 47907, USA.
Dickerhoff J; College of Pharmacy, Medicinal Chemistry and Molecular Pharmacology, 575 W Stadium Ave, Purdue University, West Lafayette, IN 47907, USA.
Yang D; College of Pharmacy, Medicinal Chemistry and Molecular Pharmacology, 575 W Stadium Ave, Purdue University, West Lafayette, IN 47907, USA.; Center for Cancer Research, Purdue University, 201 S University St, West Lafayette, IN 47906, USA.; Department of Chemistry, Purdue University, West Lafayette, IN 47906, USA.; Purdue Institute for Drug Discovery, West Lafayette, IN 47906, USA.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2021 Jul 07; Vol. 26 (14). Date of Electronic Publication: 2021 Jul 07.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Antineoplastic Agents/*pharmacology
DNA/*chemistry
Intercalating Agents/*pharmacology
Neoplasms/*drug therapy
Phenazines/*pharmacology
Animals ; Humans

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: A high-content screen identifies the vulnerability of MYC-overexpressing cells to dimethylfasudil.
Autorzy:: Zhang J; Anticancer Biosciences and the J. Michael Bishop Institute of Cancer Research, Chengdu, China.
Zhang S; Anticancer Biosciences and the J. Michael Bishop Institute of Cancer Research, Chengdu, China.
Shi Q; Anticancer Biosciences and the J. Michael Bishop Institute of Cancer Research, Chengdu, China.
Allen TD; Anticancer Biosciences and the J. Michael Bishop Institute of Cancer Research, Chengdu, China.
You F; Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Yang D; Anticancer Biosciences and the J. Michael Bishop Institute of Cancer Research, Chengdu, China.; Chengdu University of Traditional Chinese Medicine, Chengdu, China.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2021 Mar 24; Vol. 16 (3), pp. e0248355. Date of Electronic Publication: 2021 Mar 24 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/*analogs & derivatives
Antineoplastic Agents/*pharmacology
Neoplasms/*drug therapy
Proto-Oncogene Proteins c-myc/*genetics
Synthetic Lethal Mutations/*drug effects
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/pharmacology ; Cell Line, Tumor ; Humans

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Cyanidin 3- O -galactoside: A Natural Compound with Multiple Health Benefits.
Autorzy:: Liang Z; Beijing Key Laboratory of Functional Food from Plant Resources, College of Food Science & Nutritional Engineering, China Agricultural University, Beijing 100083, China.
Liang H; Beijing Key Laboratory of Functional Food from Plant Resources, College of Food Science & Nutritional Engineering, China Agricultural University, Beijing 100083, China.
Guo Y; Beijing Key Laboratory of Functional Food from Plant Resources, College of Food Science & Nutritional Engineering, China Agricultural University, Beijing 100083, China.
Yang D; Beijing Key Laboratory of Functional Food from Plant Resources, College of Food Science & Nutritional Engineering, China Agricultural University, Beijing 100083, China.; Key Laboratory of Viticulture and Enology, Ministry of Agriculture and Rural Affairs, Beijing 100083, China.; Xinghua Industrial Research Centre for Food Science and Human Health, China Agricultural University, Xinghua 225700, China.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Feb 24; Vol. 22 (5). Date of Electronic Publication: 2021 Feb 24.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Anthocyanins/*pharmacology
Anti-Inflammatory Agents/*pharmacology
Antineoplastic Agents/*pharmacology
Biological Products/*pharmacology
Galactosides/*pharmacology
Hypoglycemic Agents/*pharmacology
Phytochemicals/*pharmacology
Plant Extracts/*pharmacology
Animals ; Fruit/chemistry ; Humans

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis.
Autorzy:: Liu H; Department of Thyroid and Breast Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China.
Yang D; Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China.
Chen X; Department of Thyroid and Breast Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China.
Sun Z; Department of Thyroid and Breast Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China.
Zou Y; Department of Laboratory Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Dongcheng District, Beijing, PR China.
Chen C; Department of Thyroid and Breast Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China.
Sun S; Department of Thyroid and Breast Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, PR China.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2021 Feb; Vol. 10 (3), pp. 1043-1056. Date of Electronic Publication: 2020 Dec 31.
Typ publikacji:: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms:: Antineoplastic Agents/*therapeutic use
COVID-19/*prevention & control
Medical Oncology/*statistics & numerical data
Neoplasms/*therapy
SARS-CoV-2/*isolation & purification
Stem Cell Transplantation/*methods
COVID-19/epidemiology ; COVID-19/virology ; Humans ; Medical Oncology/methods ; Neoplasms/diagnosis ; Outcome Assessment, Health Care/methods ; Outcome Assessment, Health Care/statistics & numerical data ; Pandemics ; Prognosis ; SARS-CoV-2/physiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: A polymorphism in the cachexia-associated gene INHBA predicts efficacy of regorafenib in patients with refractory metastatic colorectal cancer.
Autorzy:: Miyamoto Y; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Schirripa M; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Suenaga M; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Cao S; Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Zhang W; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Okazaki S; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Berger MD; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Matsusaka S; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Yang D; Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Ning Y; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.
Baba H; Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Loupakis F; Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, IRCCS, Padua, Italy.
Lonardi S; Unit of Medical Oncology 1, Department of Clinical and Experimental Oncology, Istituto Oncologico Veneto, IRCCS, Padua, Italy.
Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Borelli B; Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Cremolini C; Polo Oncologico, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Yamaguchi T; Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Lenz HJ; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2020 Sep 24; Vol. 15 (9), pp. e0239439. Date of Electronic Publication: 2020 Sep 24 (Print Publication: 2020).
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Agents/*therapeutic use
Colorectal Neoplasms/*drug therapy
Inhibin-beta Subunits/*genetics
Phenylurea Compounds/*therapeutic use
Pyridines/*therapeutic use
Aged ; Alleles ; Colorectal Neoplasms/genetics ; Colorectal Neoplasms/mortality ; Colorectal Neoplasms/pathology ; Female ; Forkhead Box Protein O3/genetics ; Genotype ; Humans ; Male ; Middle Aged ; Myostatin/genetics ; Neoplasm Metastasis ; Polymorphism, Single Nucleotide ; Proportional Hazards Models ; Retrospective Studies ; Sex Factors ; Smad2 Protein/genetics ; Survival Rate

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: A Novel Imidazopyridine Derivative Exerts Anticancer Activity by Inducing Mitochondrial Pathway-Mediated Apoptosis.
Autorzy:: Wang J; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Engineering Laboratory of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy & International Academy of Targeted Therapeutics and Innovation, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Wu H; Integrative Cancer Center & Cancer Clinical Research Center, Sichuan Cancer Hospital & Institute Sichuan Cancer Center, School of Medicine University of Electronic Science and Technology of China, Chengdu 610041, China.
Song G; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Engineering Laboratory of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy & International Academy of Targeted Therapeutics and Innovation, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Yang D; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Engineering Laboratory of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy & International Academy of Targeted Therapeutics and Innovation, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Huang J; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Engineering Laboratory of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy & International Academy of Targeted Therapeutics and Innovation, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Yao X; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Engineering Laboratory of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy & International Academy of Targeted Therapeutics and Innovation, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Qin H; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Engineering Laboratory of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy & International Academy of Targeted Therapeutics and Innovation, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Chen Z; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Engineering Laboratory of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy & International Academy of Targeted Therapeutics and Innovation, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Xu Z; National & Local Joint Engineering Research Center of Targeted and Innovative Therapeutics, Chongqing Engineering Laboratory of Targeted and Innovative Therapeutics, Chongqing Key Laboratory of Kinase Modulators as Innovative Medicine, Chongqing Collaborative Innovation Center of Targeted and Innovative Therapeutics, College of Pharmacy & International Academy of Targeted Therapeutics and Innovation, Chongqing University of Arts and Sciences, Chongqing 402160, China.
Xu C; Integrative Cancer Center & Cancer Clinical Research Center, Sichuan Cancer Hospital & Institute Sichuan Cancer Center, School of Medicine University of Electronic Science and Technology of China, Chengdu 610041, China.; Pokaż więcej
Źródło:: BioMed research international [Biomed Res Int] 2020 Aug 25; Vol. 2020, pp. 4929053. Date of Electronic Publication: 2020 Aug 25 (Print Publication: 2020).
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents/*pharmacology
Apoptosis/*drug effects
Mitochondria/*drug effects
Antineoplastic Agents/administration & dosage ; Antineoplastic Agents/chemistry ; Apoptosis/physiology ; Dose-Response Relationship, Drug ; HeLa Cells ; Humans ; Imidazoles/chemistry ; Membrane Potential, Mitochondrial/drug effects ; Mitochondria/metabolism ; Pyridines/chemistry ; Time Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Clinical application of the AUC-guided dosage adjustment of docetaxel-based chemotherapy for patients with solid tumours: a single centre, prospective and randomised control study.
Autorzy:: Sun N; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, No. 42, Baiziting, Nanjing, 210009, China.
Shen B; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, No. 42, Baiziting, Nanjing, 210009, China.
Zhu J; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, No. 42, Baiziting, Nanjing, 210009, China.
Zhang X; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, No. 42, Baiziting, Nanjing, 210009, China.
Zhu H; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, No. 42, Baiziting, Nanjing, 210009, China.
Liang G; Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing, Jiangsu, China.
Yang D; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, No. 42, Baiziting, Nanjing, 210009, China.
Lu J; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, No. 42, Baiziting, Nanjing, 210009, China.
Zhang Y; Department of Medical Oncology, Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research & The Affiliated Cancer Hospital of Nanjing Medical University, No. 42, Baiziting, Nanjing, 210009, China. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2020 Jun 08; Vol. 18 (1), pp. 226. Date of Electronic Publication: 2020 Jun 08.
Typ publikacji:: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Antineoplastic Agents*/therapeutic use
Neoplasms*/drug therapy
Antineoplastic Combined Chemotherapy Protocols ; Area Under Curve ; Docetaxel/therapeutic use ; Humans ; Prospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: A Co-Delivery System of Curcumin and p53 for Enhancing the Sensitivity of Drug-Resistant Ovarian Cancer Cells to Cisplatin.
Autorzy:: Guo X; College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Fang Z; College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Zhang M; College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Yang D; College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Wang S; College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.
Liu K; College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2020 Jun 04; Vol. 25 (11). Date of Electronic Publication: 2020 Jun 04.
Typ publikacji:: Journal Article
MeSH Terms:: Drug Resistance, Neoplasm*
Anti-Inflammatory Agents, Non-Steroidal/*pharmacology
Antineoplastic Agents/*pharmacology
Cisplatin/*pharmacology
Curcumin/*pharmacology
Ovarian Neoplasms/*drug therapy
Tumor Suppressor Protein p53/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols ; Apoptosis ; Cell Proliferation ; Female ; Humans ; Ovarian Neoplasms/metabolism ; Ovarian Neoplasms/pathology ; Tumor Cells, Cultured

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Autorzy:: Yang D; Department of Environmental Health, School of Public Health, China Medical University, 77th Puhe Road, Shenyang, 110122, Liaoning, China.
He Y; Department of Central Laboratory, The First Affiliated Hospital, China Medical University, 155th Nanjing North Street, Shenyang, 110001, Liaoning, China.
Wu B; Department of Anus and Intestine Surgery, The First Affiliated Hospital, China Medical University, 155th Nanjing North Street, Shenyang, 110001, Liaoning, China.
Deng Y; Department of Environmental Health, School of Public Health, China Medical University, 77th Puhe Road, Shenyang, 110122, Liaoning, China.
Wang N; Department of Environmental Health, School of Public Health, China Medical University, 77th Puhe Road, Shenyang, 110122, Liaoning, China.
Li M; Department of Environmental Health, School of Public Health, China Medical University, 77th Puhe Road, Shenyang, 110122, Liaoning, China.
Liu Y; Department of Environmental Health, School of Public Health, China Medical University, 77th Puhe Road, Shenyang, 110122, Liaoning, China. .; Pokaż więcej
Źródło:: Journal of ovarian research [J Ovarian Res] 2020 Jan 27; Vol. 13 (1), pp. 10. Date of Electronic Publication: 2020 Jan 27.
Typ publikacji:: Journal Article
MeSH Terms:: Gene Expression Regulation, Neoplastic*
Antineoplastic Agents/*therapeutic use
Computational Biology/*methods
Gene Expression Profiling/*methods
Genetic Predisposition to Disease/*genetics
Ovarian Neoplasms/*drug therapy
Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Databases, Genetic/statistics & numerical data ; Early Detection of Cancer/methods ; Female ; Gene Ontology ; Gene Regulatory Networks ; Humans ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Ovarian Neoplasms/diagnosis ; Ovarian Neoplasms/genetics ; Progression-Free Survival ; Protein Interaction Maps/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Preparation and evaluation of self-assembly Soluplus -sodium cholate-phospholipid ternary mixed micelles of docetaxel.
Autorzy:: Jiang S; Wuya College of Innovation, Shenyang Pharmaceutical University , Shenyang , China.
Mou Y; Department of Pharmacology, Shenyang Pharmaceutical University , Shenyang , China.
He H; Wuya College of Innovation, Shenyang Pharmaceutical University , Shenyang , China.
Yang D; Wuya College of Innovation, Shenyang Pharmaceutical University , Shenyang , China.
Qin L; Wuya College of Innovation, Shenyang Pharmaceutical University , Shenyang , China.
Zhang F; Wuya College of Innovation, Shenyang Pharmaceutical University , Shenyang , China.
Zhang P; Wuya College of Innovation, Shenyang Pharmaceutical University , Shenyang , China.; Pokaż więcej
Źródło:: Drug development and industrial pharmacy [Drug Dev Ind Pharm] 2019 Nov; Vol. 45 (11), pp. 1788-1798. Date of Electronic Publication: 2019 Sep 10.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents/*administration & dosage
Docetaxel/*administration & dosage
Drug Carriers/*chemistry
Drug Compounding/*methods
Neoplasms/*drug therapy
Animals ; Antineoplastic Agents/pharmacokinetics ; Biological Availability ; Docetaxel/pharmacokinetics ; Drug Liberation ; HT29 Cells ; Humans ; Injections, Intralesional ; Mice ; Micelles ; Neoplasms/pathology ; Particle Size ; Phospholipids/chemistry ; Polyethylene Glycols/chemistry ; Polyvinyls/chemistry ; Rats ; Sodium Cholate/chemistry ; Solubility ; Xenograft Model Antitumor Assays

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma.
Autorzy:: Wang X; School of Life Sciences, Jilin University, Changchun 130012, China. .
Zhao Y; School of Life Sciences, Jilin University, Changchun 130012, China. .
Dong S; School of Life Sciences, Jilin University, Changchun 130012, China. .
Lee RJ; Division of Pharmaceutics and Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. .
Yang D; Department of Chemistry and Pharmacy, Zhuhai College of Jilin University, Zhuhai 519041, China. .
Zhang H; School of Life Sciences, Jilin University, Changchun 130012, China. zhang_.
Teng L; School of Life Sciences, Jilin University, Changchun 130012, China. .; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2019 Sep 30; Vol. 24 (19). Date of Electronic Publication: 2019 Sep 30.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents/*administration & dosage
Cell-Penetrating Peptides/*metabolism
Glioma/*drug therapy
Glioma/*metabolism
Transferrin/*metabolism
Animals ; Blood-Brain Barrier/metabolism ; Cell Line, Tumor ; Cell Survival/drug effects ; Cell-Penetrating Peptides/chemistry ; Disease Models, Animal ; Doxorubicin/administration & dosage ; Doxorubicin/analogs & derivatives ; Drug Delivery Systems ; Humans ; Liposomes ; Mice ; Polyethylene Glycols/administration & dosage ; Transferrin/chemistry ; Xenograft Model Antitumor Assays

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Thiophene Derivatives as Anticancer Agents and Their Delivery to Tumor Cells Using Albumin Nanoparticles.
Autorzy:: Cai G; College of Life Sciences, Jilin University, Changchun 130012, China. .
Wang S; College of Life Sciences, Jilin University, Changchun 130012, China. .
Zhao L; College of Chemistry, Jilin University, Changchun 130012, China. .
Sun Y; College of Life Sciences, Jilin University, Changchun 130012, China. .
Yang D; School of Pharmaceutical and Food Sciences, Zhuhai College of Jilin University, Zhuhai 519041, China. .
Lee RJ; College of Life Sciences, Jilin University, Changchun 130012, China. .; Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy, The Ohio State University, Columbus, OH 43210, USA. .
Zhao M; College of Life Sciences, Jilin University, Changchun 130012, China. .
Zhang H; College of Life Sciences, Jilin University, Changchun 130012, China. zhang_.
Zhou Y; College of Life Sciences, Jilin University, Changchun 130012, China. .; Pokaż więcej
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2019 Jan 06; Vol. 24 (1). Date of Electronic Publication: 2019 Jan 06.
Typ publikacji:: Journal Article
MeSH Terms:: Albumins/*chemistry
Antineoplastic Agents/*pharmacology
Drug Carriers/*chemistry
Nanoparticles/*chemistry
Thiophenes/*pharmacology
Biological Transport ; Cell Line, Tumor ; Cell Survival/drug effects ; Delayed-Action Preparations/chemistry ; Drug Design ; Drug Liberation ; Humans ; Molecular Structure ; Particle Size ; Reactive Oxygen Species/metabolism ; Solubility ; Structure-Activity Relationship ; Surface Properties

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: [Value of European Organisation for Research and Treatment of Cancer score system for predication of immediate postoperative intravesical instillation of pirarubicin after transurethral resection of non-muscle invasive bladder cancer].
Autorzy:: Ding XL; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Burma Road, No. 374, Kunming 650101, China.
Yang DL; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Burma Road, No. 374, Kunming 650101, China.
Yan RP; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Burma Road, No. 374, Kunming 650101, China.
Li ZP; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Burma Road, No. 374, Kunming 650101, China.
Ye CW; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Burma Road, No. 374, Kunming 650101, China.
He J; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Burma Road, No. 374, Kunming 650101, China.
Yu L; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Burma Road, No. 374, Kunming 650101, China.
He SC; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Burma Road, No. 374, Kunming 650101, China.
Li HD; Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Burma Road, No. 374, Kunming 650101, China.; Pokaż więcej
Źródło:: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2018 Apr 23; Vol. 40 (4), pp. 308-312.
Typ publikacji:: Journal Article
MeSH Terms:: Antineoplastic Agents/*administration & dosage
Doxorubicin/*analogs & derivatives
Urinary Bladder Neoplasms/*drug therapy
Urinary Bladder Neoplasms/*surgery
Administration, Intravesical ; Disease Progression ; Doxorubicin/administration & dosage ; Humans ; Neoplasm Recurrence, Local/prevention & control ; Postoperative Care/methods ; Risk Assessment ; Risk Factors ; Time Factors ; Urinary Bladder Neoplasms/pathology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Yang D"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji